These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 7913943

  • 1. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
    Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ.
    J Immunol; 1994 Aug 15; 153(4):1697-706. PubMed ID: 7913943
    [Abstract] [Full Text] [Related]

  • 2. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS.
    Cancer Gene Ther; 2000 Jun 15; 7(6):826-38. PubMed ID: 10880012
    [Abstract] [Full Text] [Related]

  • 5. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
    Berman RM, Suzuki T, Tahara H, Robbins PD, Narula SK, Lotze MT.
    J Immunol; 1996 Jul 01; 157(1):231-8. PubMed ID: 8683120
    [Abstract] [Full Text] [Related]

  • 6. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS, Ip G, Wright MA, Young MR.
    Cancer Res; 1995 Feb 15; 55(4):885-90. PubMed ID: 7850804
    [Abstract] [Full Text] [Related]

  • 7. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
    Tahara H, Zitvogel L, Storkus WJ, Zeh HJ, McKinney TG, Schreiber RD, Gubler U, Robbins PD, Lotze MT.
    J Immunol; 1995 Jun 15; 154(12):6466-74. PubMed ID: 7759882
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S, Krinock RA, Matsumura T, Sussman JJ, Fox BA, Chang AE, Terman DS.
    J Immunol; 1994 Feb 01; 152(3):1277-88. PubMed ID: 8301131
    [Abstract] [Full Text] [Related]

  • 9. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J, Hu P, Khawli LA, Epstein AL.
    Cancer Res; 2003 Dec 01; 63(23):8384-92. PubMed ID: 14679000
    [Abstract] [Full Text] [Related]

  • 10. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
    Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G.
    J Hepatol; 2006 Nov 01; 45(5):662-72. PubMed ID: 16935390
    [Abstract] [Full Text] [Related]

  • 11. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M, Goedegebuure PS, Burger UL, Sadanaga N, Chang MP, Eberlein TJ.
    J Immunol; 1998 Jan 01; 160(1):334-44. PubMed ID: 9551989
    [Abstract] [Full Text] [Related]

  • 12. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 13. The role of IFN-gamma in rejection of established tumors by IL-12 : source of production and target.
    Segal JG, Lee NC, Tsung YL, Norton JA, Tsung K.
    Cancer Res; 2002 Aug 15; 62(16):4696-703. PubMed ID: 12183428
    [Abstract] [Full Text] [Related]

  • 14. gamma-Interferon plays a key role in T-cell-induced tumor regression.
    Tuttle TM, McCrady CW, Inge TH, Salour M, Bear HD.
    Cancer Res; 1993 Feb 15; 53(4):833-9. PubMed ID: 8428364
    [Abstract] [Full Text] [Related]

  • 15. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 16. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A, Di Carlo E, Musiani P, Rosso O, Meazza R, Chiodoni C, Colombo MP, Ferrini S.
    Eur J Immunol; 2002 Jul 01; 32(7):1914-23. PubMed ID: 12115611
    [Abstract] [Full Text] [Related]

  • 17. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 18. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.
    Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM, Hamilton TA.
    J Immunol; 1996 Jan 15; 156(2):693-9. PubMed ID: 8543822
    [Abstract] [Full Text] [Related]

  • 19. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.
    Weber JS, Rosenberg SA.
    Cancer Res; 1988 Oct 15; 48(20):5818-24. PubMed ID: 3139284
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP.
    Cancer Res; 2002 Aug 01; 62(15):4390-7. PubMed ID: 12154045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.